Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma.

Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q33858898
GALNT14 genotype, α-fetoprotein and therapeutic side effects predict post-chemotherapy survival in patients with advanced hepatocellular carcinoma.A single nucleotide polymorphism on the GALNT14 gene as an effective predictor of response to chemotherapy in advanced hepatocellular carcinoma.Intratumoral chemotherapy for lung cancer: re-challenge current targeted therapies.Novel HBsAg mutations correlate with hepatocellular carcinoma, hamper HBsAg secretion and promote cell proliferation in vitro.Should cirrhosis change our attitude towards treating non-hepatic cancer?Enhanced 5-fluorouracil cytotoxicity in high COX-2 expressing hepatocellular carcinoma cells by wogonin via the PI3K/Akt pathway.Acute exacerbation of hepatitis C in hepatocellular carcinoma patients receiving chemotherapy.Significant renoprotective effect of telbivudine during preemptive antiviral therapy in advanced liver cancer patients receiving cisplatin-based chemotherapy: a case-control study.Combinations of single nucleotide polymorphisms WWOX-rs13338697, GALNT14-rs9679162 and rs6025211 effectively stratify outcomes of chemotherapy in advanced hepatocellular carcinoma.Peroxiredoxin 3 is resistant to oxidation-induced apoptosis of Hep-3b cells.GALNT14 genotype effectively predicts the therapeutic response in unresectable hepatocellular carcinoma treated with transcatheter arterial chemoembolization.
P2860

Retrospective comparison between a regular and a split-dose protocol of 5-fluorouracil, cisplatin, and mitoxantrone for the treatment of far advanced hepatocellular carcinoma.

Item
http://www.wikidata.org/entity/Q33858898
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Retrospective comparison betwe ...... nced hepatocellular carcinoma.
@ast
Retrospective comparison betwe ...... nced hepatocellular carcinoma.
@en
type
label
Retrospective comparison betwe ...... nced hepatocellular carcinoma.
@ast
Retrospective comparison betwe ...... nced hepatocellular carcinoma.
@en
prefLabel
Retrospective comparison betwe ...... nced hepatocellular carcinoma.
@ast
Retrospective comparison betwe ...... nced hepatocellular carcinoma.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P932
P356
P1433
P1476
Retrospective comparison betwe ...... nced hepatocellular carcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P478
P577
P5875
P6179
P698
P932